Targeted inactivation of Salmonella Agona metabolic genes by group II introns and in vivo assessment of pathogenicity and anti-tumour activity in mouse model

The fight against cancer has been a never-ending battle. Limitations of conventional therapies include lack of selectivity, poor penetration and highly toxic to the host. Using genetically modified bacteria as a tumour therapy agent has gained the interest of scientist from the past few decades. Low...

Full description

Bibliographic Details
Main Authors: Chin, Piaw Gwee, Chai, Hoon Khoo, Swee, Keong Yeap, Geok, Chin Tan, Yoke, Kqueen Cheah
Format: Article
Language:English
Published: PeerJ 2019
Online Access:http://psasir.upm.edu.my/id/eprint/82141/1/Targeted%20inactivation%20.pdf
_version_ 1825951533647265792
author Chin, Piaw Gwee
Chai, Hoon Khoo
Swee, Keong Yeap
Geok, Chin Tan
Yoke, Kqueen Cheah
author_facet Chin, Piaw Gwee
Chai, Hoon Khoo
Swee, Keong Yeap
Geok, Chin Tan
Yoke, Kqueen Cheah
author_sort Chin, Piaw Gwee
collection UPM
description The fight against cancer has been a never-ending battle. Limitations of conventional therapies include lack of selectivity, poor penetration and highly toxic to the host. Using genetically modified bacteria as a tumour therapy agent has gained the interest of scientist from the past few decades. Low virulence and highly tolerability of Salmonella spp. in animals and humans make it as the most studied pathogen with regards to anti-tumour therapy. The present study aims to construct a genetically modified S. Agona auxotroph as an anti-tumour agent. LeuB and ArgD metabolic genes in ΔSopBΔSopD double knockout S. Agona were successfully knocked out using a Targetron gene knockout system. The knockout was confirmed by colony PCR and the strains were characterized in vitro and in vivo. The knockout of metabolic genes causes significant growth defect in M9 minimal media. Quadruple knockout ΔSopBΔSopDΔLeuBΔArgD (BDLA) exhibited lowest virulence among all of the strains in all parameters including bacterial load, immunity profile and histopathology studies. In vivo anti-tumour study on colorectal tumour bearing-BALB/c mice revealed that all strains of S. Agona were able to suppress the growth of the large solid tumour as compared with negative control and ΔLeuBΔArgD (LA) and BDLA auxotroph showed better efficacy. Interestingly, higher level of tumour growth suppression was noticed in large tumour. However, multiple administration of bacteria dosage did not increase the tumour suppression efficacy. In this study, the virulence of BDLA knockout strain was slightly reduced and tumour growth suppression efficacy was successfully enhanced, which provide a valuable starting point for the development of S. Agona as anti-tumour agent.
first_indexed 2024-03-06T10:31:26Z
format Article
id upm.eprints-82141
institution Universiti Putra Malaysia
language English
last_indexed 2024-03-06T10:31:26Z
publishDate 2019
publisher PeerJ
record_format dspace
spelling upm.eprints-821412021-02-01T19:45:39Z http://psasir.upm.edu.my/id/eprint/82141/ Targeted inactivation of Salmonella Agona metabolic genes by group II introns and in vivo assessment of pathogenicity and anti-tumour activity in mouse model Chin, Piaw Gwee Chai, Hoon Khoo Swee, Keong Yeap Geok, Chin Tan Yoke, Kqueen Cheah The fight against cancer has been a never-ending battle. Limitations of conventional therapies include lack of selectivity, poor penetration and highly toxic to the host. Using genetically modified bacteria as a tumour therapy agent has gained the interest of scientist from the past few decades. Low virulence and highly tolerability of Salmonella spp. in animals and humans make it as the most studied pathogen with regards to anti-tumour therapy. The present study aims to construct a genetically modified S. Agona auxotroph as an anti-tumour agent. LeuB and ArgD metabolic genes in ΔSopBΔSopD double knockout S. Agona were successfully knocked out using a Targetron gene knockout system. The knockout was confirmed by colony PCR and the strains were characterized in vitro and in vivo. The knockout of metabolic genes causes significant growth defect in M9 minimal media. Quadruple knockout ΔSopBΔSopDΔLeuBΔArgD (BDLA) exhibited lowest virulence among all of the strains in all parameters including bacterial load, immunity profile and histopathology studies. In vivo anti-tumour study on colorectal tumour bearing-BALB/c mice revealed that all strains of S. Agona were able to suppress the growth of the large solid tumour as compared with negative control and ΔLeuBΔArgD (LA) and BDLA auxotroph showed better efficacy. Interestingly, higher level of tumour growth suppression was noticed in large tumour. However, multiple administration of bacteria dosage did not increase the tumour suppression efficacy. In this study, the virulence of BDLA knockout strain was slightly reduced and tumour growth suppression efficacy was successfully enhanced, which provide a valuable starting point for the development of S. Agona as anti-tumour agent. PeerJ 2019-01 Article PeerReviewed text en http://psasir.upm.edu.my/id/eprint/82141/1/Targeted%20inactivation%20.pdf Chin, Piaw Gwee and Chai, Hoon Khoo and Swee, Keong Yeap and Geok, Chin Tan and Yoke, Kqueen Cheah (2019) Targeted inactivation of Salmonella Agona metabolic genes by group II introns and in vivo assessment of pathogenicity and anti-tumour activity in mouse model. PeerJ. pp. 1-22. ISSN 2167-8359 10.7717/peerj.5989
spellingShingle Chin, Piaw Gwee
Chai, Hoon Khoo
Swee, Keong Yeap
Geok, Chin Tan
Yoke, Kqueen Cheah
Targeted inactivation of Salmonella Agona metabolic genes by group II introns and in vivo assessment of pathogenicity and anti-tumour activity in mouse model
title Targeted inactivation of Salmonella Agona metabolic genes by group II introns and in vivo assessment of pathogenicity and anti-tumour activity in mouse model
title_full Targeted inactivation of Salmonella Agona metabolic genes by group II introns and in vivo assessment of pathogenicity and anti-tumour activity in mouse model
title_fullStr Targeted inactivation of Salmonella Agona metabolic genes by group II introns and in vivo assessment of pathogenicity and anti-tumour activity in mouse model
title_full_unstemmed Targeted inactivation of Salmonella Agona metabolic genes by group II introns and in vivo assessment of pathogenicity and anti-tumour activity in mouse model
title_short Targeted inactivation of Salmonella Agona metabolic genes by group II introns and in vivo assessment of pathogenicity and anti-tumour activity in mouse model
title_sort targeted inactivation of salmonella agona metabolic genes by group ii introns and in vivo assessment of pathogenicity and anti tumour activity in mouse model
url http://psasir.upm.edu.my/id/eprint/82141/1/Targeted%20inactivation%20.pdf
work_keys_str_mv AT chinpiawgwee targetedinactivationofsalmonellaagonametabolicgenesbygroupiiintronsandinvivoassessmentofpathogenicityandantitumouractivityinmousemodel
AT chaihoonkhoo targetedinactivationofsalmonellaagonametabolicgenesbygroupiiintronsandinvivoassessmentofpathogenicityandantitumouractivityinmousemodel
AT sweekeongyeap targetedinactivationofsalmonellaagonametabolicgenesbygroupiiintronsandinvivoassessmentofpathogenicityandantitumouractivityinmousemodel
AT geokchintan targetedinactivationofsalmonellaagonametabolicgenesbygroupiiintronsandinvivoassessmentofpathogenicityandantitumouractivityinmousemodel
AT yokekqueencheah targetedinactivationofsalmonellaagonametabolicgenesbygroupiiintronsandinvivoassessmentofpathogenicityandantitumouractivityinmousemodel